Epstein-Barr virus, human cytomegalovirus, human herpesvirus 6 and 7, human adenovirus, John Cunningham virus, and BK virus are not associated with gliomas in humans
More details
Hide details
Department of Clinical Nursing, Medical University of Warsaw, Poland
Department of Neurosurgery, John Paul II Western Hospital, Grodzisk Mazowiecki, Poland
Department of Immunology, Transplantology, and Internal Diseases, Medical University of Warsaw, Poland
Bożena Czarkowska-Pączek   

Department of Clinical Nursing, Medical University of Warsaw, E. Ciolka 27, 01-445 Warsaw, Poland. Tel./Fax: +4822 836 09 72.
Submission date: 2021-07-06
Final revision date: 2021-11-10
Acceptance date: 2021-11-10
Online publication date: 2021-11-17
The literature points to several viruses associated with brain carcinogenesis, including gliomas.

The aim of this study was to assess the presence of several viruses in gliomas and plasma from patients with brain tumor and the possible association of viral positivity with the clinical course.

Material and methods:
The study group consisted of 37 patients with gliomas who were subjected to surgery. Mean patient age was 54.59 (SD 15.85) years. The presence of viral DNA was assessed using real-time polymerase chain reaction.

Results and discussion:
We did not confirm any BK virus, John Cunningham virus, or human adenovirus-positive gliomas. The percentage of patients with gliomas positive for Epstein-Barr virus (EBV), cytomegalovirus (CMV), and human herpesvirus (HHV) 6 and 7 was 18.9%, 8.1%, 2.7%, and 10.8%, respectively. We did not confirm the co-occurrence of glioma and plasma viral positivity. Fisher’s test did not reveal the influence of viral infection on the risk of death. We did not detect any differences regarding sex, WHO classification of gliomas, or the functional impairment evaluated by the Karnofsky scale index at admission to the hospital in the group of patients positive or negative for EBV, CMV, or HHV6.

We cannot confirm an association of the investigated viruses with gliomas.

No external funding.
Akhtar S, Vranic S, Cyprian FS, Al Moustafa AE. Epstein-Barr Virus in Gliomas: Cause, Association, or Artifact? Front Oncol. 2018;8:123.
Mudassar F, Shen H, O’Neill G, Hau E. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas. J Exp Clin Cancer Res. 2020;39(1):208.
Perry A, Wesseling P. Histologic classification of gliomas. Handb Clin Neurol. 2016;134:71–95.
Ostrom QT, Bauchet L, Davis FG, et al. The epidemiology of glioma in adults: a ‘state of the science’ review. Neuro Oncol. 2014;16(7):896–913.
Péus D, Newcomb N, Hofer S. Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation. BMC Med Inform Decis Mak. 2013;13:72.
Morales-Sánchez A, Fuentes-Pananá EM. Human viruses and cancer. Viruses. 2014;6(10):4047–79.
Rahbar A, Orrego A, Peredo I, et al. Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. J Clin Virol. 2013;57(1):36–42.
Zavala-Vega S, Palma-Lara I, Ortega-Soto E, et al. Role of Epstein-Barr Virus in Glioblastoma. Crit Rev Oncog. 2019;24(4):307–338.
Tognon M, Casalone R, Martini F, et al. Large T antigen coding sequences of two DNA tumor viruses, BK and SV40, and nonrandom chromosome changes in two glioblastoma cell lines. Cancer Genet Cytogenet. 1996;90(1):17–23.
Delbue S, Pagani E, Guerini FR, et al. Distribution, characterization and significance of polyomavirus genomic sequences in tumors of the brain and its covering. J Med Virol. 2005;77(3):447–454.
Boldorini R, Pagani E, Car PG, et al. Molecular characterisation of JC virus strains detected in human brain tumours. Pathology. 2003;35(3):248–253.
Crawford JR, Santi MR, Thorarinsdottir HK, et al. Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas. J Clin Virol. 2009;46(1):37–42.
Lin CT, Leibovitch EC, Almira-Suarez MI, Jacobson S. Human herpesvirus multiplex ddPCR detection in brain tissue from low- and high-grade astrocytoma cases and controls. Infect Agent Cancer. 2016;26;11:32.
Kryst P, Poletajew S, Wyczałkowska-Tomasik A, et al. Epstein-Barr Virus and Human Adenovirus Viremia in Renal Tumors Is Associated with Histological Features of Malignancy. J Clin Med. 2020;9:3195.
Rollison DE, Utaipat U, Ryschkewitsch C, et al. Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories. Int J Cancer. 2005;113(5):769–774.
Ahye N, Bellizzi A, May D, Wollebo HS. The Role of the JC Virus in Central Nervous System Tumorigenesis. Int J Mol Sci. 2020;21(17):6236.
Kim JY, Koralnik IJ, LeFave M, Segal RA, Pfister LA, Pomeroy SL. Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences. Neuro Oncol. 2002;4(3):165–170.
Weggen S, Bayer TA, von Deimling A, et al. Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas. Brain Pathol. 2000;10(1):85–92.
Zang J, Zheng MH, Cao XL, et al. Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway. Cell Commun Signa. 2020;18(1):135.
Actor JK. Clinical Virology. Elsevier's Integrated Review Immunology and Microbiology. 2012;129–138.
Chi J, Gu B, Zhang C, et al. Human herpesvirus 6 latent infection in patients with glioma. J Infect Dis. 2012;206(9):1394–1398.
Strong MJ, Blanchard E 4th, Lin Z, et al. A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus – tumor association. Acta Neuropathol Commun. 2016;4(1):71.
Elgui de Oliveira D, Müller-Coan BG, Pagano JS. Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers. Trends Microbiol. 2016;24(8):649–664.
Limam S, Missaoui N, Mestiri S, et al. Epstein-Barr virus infection in gliomas. Curr Res Transl Med. 2019;67(4):129–133. doi: 10.1016/j.retram.2019.06.002.
Farias KPRA, Moreli ML, Floriano VG, da Costa VG. Evidence based on a meta-analysis of human cytomegalovirus infection in glioma. Arch Virol. 2019;164(5):1249–1257.
Xing Y, Wang Y, Wang S, et al. Human cytomegalovirus infection contributes to glioma disease progression via upregulating endocan expression. Transl Res. 2016;177:113–126.
Zavala-Vega S, Castro-Escarpulli G, Hernández-Santos H, et al. An overview of the infection of CMV, HSV 1/2 and EBV in Mexican patients with glioblastoma multiforme. Pathol Res Pract. 2017;213(3):271–276.
Cosset É, Petty TJ, Dutoit V, et al. Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response. Int J Cancer. 2014;135(6):1381–9.
Hashida Y, Taniguchi A, Yawata T, et al. Prevalence of human cytomegalovirus, polyomaviruses, and oncogenic viruses in glioblastoma among Japanese subjects. Infect Agent Cancer. 2015;10:3.
Goerig N, Semrau S, Frey B, et al. Clinically significant CMV (re)activation during or after radiotherapy/chemotherapy of the brain: Correlation with neurological deterioration and improvement upon antiviral treatment. Strahlenther Onkol. 2016;192(7):489–97.